Acute Distress Respiratory Syndrome After Subarachnoid Hemorrhage: Incidence and Impact on the Outcome in a Large Multicenter, Retrospective Cohort.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
06 2021
Historique:
received: 10 06 2020
accepted: 14 09 2020
pubmed: 22 10 2020
medline: 30 9 2021
entrez: 21 10 2020
Statut: ppublish

Résumé

Respiratory complications are frequently reported after aneurismal subarachnoid hemorrhage (aSAH), even if their association with outcome remains controversial. Acute respiratory distress syndrome (ARDS) is one of the most severe pulmonary complications after aSAH, with a reported incidence ranging from 11 to 50%. This study aims to assess in a large cohort of aSAH patients, during the first week after an intensive care unit (ICU) admission, the incidence of ARDS defined according to the Berlin criteria and its effect on outcome. This is a multicentric, retrospective cohort study in 3 European intensive care units. We collected data between January 2009 and December 2017. We included adult patients (≥ 18 years) with a diagnosis of aSAH admitted to the ICU. A total of 855 patients fulfilled the inclusion criteria. ARDS was assessable in 851 patients. The cumulative incidence of ARDS was 2.2% on the first day since ICU admission, 3.2% on day three, and 3.6% on day seven. At the univariate analysis, ARDS was associated with a poor outcome (p = 0.005) at ICU discharge, and at the multivariable analysis, patients with ARDS showed a worse neurological outcome (Odds ratio = 3.00, 95% confidence interval 1.16-7.72; p = 0.023). ARDS has a low incidence in the first 7 days of ICU stay after aSAH, but it is associated with worse outcome.

Sections du résumé

BACKGROUND
Respiratory complications are frequently reported after aneurismal subarachnoid hemorrhage (aSAH), even if their association with outcome remains controversial. Acute respiratory distress syndrome (ARDS) is one of the most severe pulmonary complications after aSAH, with a reported incidence ranging from 11 to 50%. This study aims to assess in a large cohort of aSAH patients, during the first week after an intensive care unit (ICU) admission, the incidence of ARDS defined according to the Berlin criteria and its effect on outcome.
METHODS
This is a multicentric, retrospective cohort study in 3 European intensive care units. We collected data between January 2009 and December 2017. We included adult patients (≥ 18 years) with a diagnosis of aSAH admitted to the ICU.
RESULTS
A total of 855 patients fulfilled the inclusion criteria. ARDS was assessable in 851 patients. The cumulative incidence of ARDS was 2.2% on the first day since ICU admission, 3.2% on day three, and 3.6% on day seven. At the univariate analysis, ARDS was associated with a poor outcome (p = 0.005) at ICU discharge, and at the multivariable analysis, patients with ARDS showed a worse neurological outcome (Odds ratio = 3.00, 95% confidence interval 1.16-7.72; p = 0.023).
CONCLUSIONS
ARDS has a low incidence in the first 7 days of ICU stay after aSAH, but it is associated with worse outcome.

Identifiants

pubmed: 33083966
doi: 10.1007/s12028-020-01115-x
pii: 10.1007/s12028-020-01115-x
pmc: PMC7575216
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1000-1008

Références

Etminan N, Chang H-S, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76:588–97.
doi: 10.1001/jamaneurol.2019.0006
Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med. 2006;34:196–202.
doi: 10.1097/01.CCM.0000194540.44020.8E
Kramer AH, Bleck TP, Dumont AS, Kassell NF, Olson C, Nathan B. Implications of early versus late bilateral pulmonary infiltrates in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;10:20–7.
doi: 10.1007/s12028-008-9137-0
Elmer J, Hou P, Wilcox SR, Chang Y, Schreiber H, Okechukwu I, et al. Acute respiratory distress syndrome after spontaneous intracerebral hemorrhage*. Crit Care Med. 2013;41:1992–2001.
doi: 10.1097/CCM.0b013e31828a3f4d
Veeravagu A, Chen Y-R, Ludwig C, Rincon F, Maltenfort M, Jallo J, et al. Acute lung injury in patients with subarachnoid hemorrhage: a nationwide inpatient sample study. World Neurosurg. 2014;82:e235–e241241.
doi: 10.1016/j.wneu.2014.02.030
Kitamura Y, Nomura M, Shima H, Nobumasa K, Kuramitsu T, Chang C-C, et al. Acute lung injury associated with systemic inflammatory response syndrome following subarachnoid hemorrhage: a survey by the Shonan Neurosurgical Association. Neurol Med Chir (Tokyo). 2010;50:456–60.
doi: 10.2176/nmc.50.456
Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–33.
pubmed: 22797452
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81–4.
doi: 10.1016/S0140-6736(74)91639-0
Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51:1457.
doi: 10.1136/jnnp.51.11.1457
Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ESJ, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21–7.
doi: 10.1227/01.NEU.0000218821.34014.1B
Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B. Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma. 1998;15:587–97.
doi: 10.1089/neu.1998.15.587
Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044–54.
doi: 10.1136/jnnp.54.12.1044
Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716–22.
doi: 10.1109/TAC.1974.1100705
R Core Team. R: A Language and Environment for Statistical Computing. 2018.
Armstrong JR, Mosher BD. Aspiration pneumonia after stroke: intervention and prevention. Neurohospitalist. 2011;1:85–93.
doi: 10.1177/1941875210395775
Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, et al. Medical complications after stroke: a multicenter study. Stroke. 2000;31:1223–9.
doi: 10.1161/01.STR.31.6.1223
Hoffmann S, Harms H, Ulm L, Nabavi DG, Mackert B-M, Schmehl I, et al. Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia—the PREDICT study. J Cereb Blood Flow Metab. 2017;37:3671–82.
doi: 10.1177/0271678X16671964
Bruder N, Rabinstein A. The participants in the international multi-disciplinary consensus conference on the critical care management of subarachnoid hemorrhage. Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15:257. https://doi.org/10.1007/s12028-011-9598-4 .
doi: 10.1007/s12028-011-9598-4 pubmed: 21761273
Muroi C, Keller M, Pangalu A, Fortunati M, Yonekawa Y, Keller E. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20:188–92.
doi: 10.1097/ANA.0b013e3181778156
Mascia L. Acute lung injury in patients with severe brain injury: a double hit model. Neurocrit Care. 2009;11:417–26.
doi: 10.1007/s12028-009-9242-8
Rincon F, Kang J, Maltenfort M, Vibbert M, Urtecho J, Athar MK, et al. Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med. 2014;42:387–96.
doi: 10.1097/CCM.0b013e3182a27732
Maas AIR, Marmarou A, Murray GD, Teasdale SGM, Steyerberg EW. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007;24:232–8.
doi: 10.1089/neu.2006.0024
Frisvold SK, Robba C, Guerin C. What respiratory targets should be recommended in patients with brain injury and respiratory failure? Intensive Care Med. 2019;45:683–6.
doi: 10.1007/s00134-019-05556-7
Futier E, Constantin JM, Jaber S. Protective lung ventilation in operating room: a systematic review. Minerva Anestesiol. 2014;80:726–35.
pubmed: 24226493
Guo L, Wang W, Zhao N, Guo L, Chi C, Hou W, et al. Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis. Crit Care. 2016;20:226.
doi: 10.1186/s13054-016-1396-0
Elmer J, Scutella M, Pullalarevu R, Wang B, Vaghasia N, Trzeciak S, et al. The association between hyperoxia and patient outcomes after cardiac arrest: analysis of a high-resolution database. Intensive Care Med. 2015;41:49–57. https://doi.org/10.1007/s00134-014-3555-6 .
doi: 10.1007/s00134-014-3555-6 pubmed: 25472570
Tejerina E, Pelosi P, Muriel A, Peñuelas O, Sutherasan Y, Frutos-Vivar F, et al. Association between ventilatory settings and development of acute respiratory distress syndrome in mechanically ventilated patients due to brain injury. J Crit Care. 2017;38:341–5.
doi: 10.1016/j.jcrc.2016.11.010

Auteurs

Aurélien Mazeraud (A)

Neurointensive Care Unit, GHU Paris - Psychiatrie et neurosciences, rue Cabanis 1, 75014, Paris, France.
School of Medicine and Surgery, University of Milano - Bicocca, Via Cadore 48, 20900, Monza, Italy.

Chiara Robba (C)

Department of Anaesthesia and Intensive Care, Policlinico San Martino IRCCS for Oncology and Neuroscience, Largo R.Benzi 10, 16132, Genova, Italy.

Paola Rebora (P)

School of Medicine and Surgery, University of Milano - Bicocca, Via Cadore 48, 20900, Monza, Italy.

Carolina Iaquaniello (C)

School of Medicine and Surgery, University of Milano - Bicocca, Via Cadore 48, 20900, Monza, Italy.

Alessia Vargiolu (A)

School of Medicine and Surgery, University of Milano - Bicocca, Via Cadore 48, 20900, Monza, Italy.

Verena Rass (V)

Department of Neurology, Neurological Intensive Care Unit, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Elisa Gouvea Bogossian (EG)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.

Raimund Helbok (R)

Department of Neurology, Neurological Intensive Care Unit, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Fabio Silvio Taccone (FS)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.

Giuseppe Citerio (G)

School of Medicine and Surgery, University of Milano - Bicocca, Via Cadore 48, 20900, Monza, Italy. giuseppe.citerio@unimib.it.
Neurointensive Care Unit, San Gerardo Hospital, ASST-Monza, Via G. B. Pergolesi 33, 20835, Monza, Italy. giuseppe.citerio@unimib.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH